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Abstract
Background:  The cell cycles of the Xenopus laevis embryo undergo extensive remodeling
beginning at the midblastula transition (MBT) of early development. Cell divisions 2–12 consist of
rapid cleavages without gap phases or cell cycle checkpoints. Some remodeling events depend upon
a critical nucleo-cytoplasmic ratio, whereas others rely on a maternal timer controlled by cyclin E/
Cdk2 activity. One key event that occurs at the MBT is the degradation of maternal Wee1, a
negative regulator of cyclin-dependent kinase (Cdk) activity.
Results: In order to assess the effect of Wee1 on embryonic cell cycle remodeling, Wee1 mRNA
was injected into one-cell stage embryos. Overexpression of Wee1 caused cell cycle delay and
tyrosine phosphorylation of Cdks prior to the MBT. Furthermore, overexpression of Wee1
disrupted key developmental events that normally occur at the MBT such as the degradation of
Cdc25A, cyclin E, and Wee1. Overexpression of Wee1 also resulted in post-MBT apoptosis,
tyrosine phosphorylation of Cdks and persistence of cyclin E/Cdk2 activity. To determine whether
Cdk2 was required specifically for the survival of the embryo, the cyclin E/Cdk2 inhibitor, ∆34-Xic1,
was injected in embryos and also shown to induce apoptosis.
Conclusion:  Taken together, these data suggest that W e e 1  t r i g g e r s  a p optosis through the
disruption of the cyclin E/Cdk2 timer. In contrast to Wee1 and ∆34-Xic1, altering Cdks by
expression of Chk1 and Chk2 kinases blocks rather than promotes apoptosis and causes
premature degradation of Cdc25A. Collectively, these data implicate Cdc25A as a key player in the
developmentally regulated program of apoptosis in X. laevis embryos.
Background
The early Xenopus laevis embryo provides a rich context in
which to investigate cell cycle regulation and the interplay
between the cell cycle and development. The first twelve
cleavage cycles following fertilization consist of rapid
oscillations between S and M phase without intervening
gap phases. These cell cycles do not engage checkpoints in
response to damaged or unreplicated DNA [1-3]. Rather,
embryonic cells that have incurred such assaults to the
genome die by a maternally regulated program of apopto-
sis during gastrulation [2-4]. Beginning at the midblastula
transition (MBT), cell cycles lengthen, acquiring gap
phases and operable cell cycle checkpoints [5,6]. Further-
more, damaged or unreplicated DNA may trigger abnor-
mal development but generally will not induce apoptosis
[2,3]. Although the molecular players in cell cycle remod-
eling during the early development of X. laevis have been
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well characterized, little is known about the underlying
controls that govern these events.
Early embryonic cell cycles are regulated by three cyclin-
dependent kinase (Cdk) complexes. Cyclin A/Cdk1 and
cyclin B/Cdk1 are the M-phase Cdks, and cyclin E/Cdk2 is
the S-phase Cdk [7,8], although their functions may over-
lap [9]. The activity of the mitotic Cdk complexes are con-
trolled by cyclin synthesis and degradation and by
inhibitory phosphorylations on threonine 14 and tyro-
sine 15 by Wee1 and Myt 1 kinases [10,11]. Phosphoryla-
tion-mediated inhibition of Cdks is counteracted by
members of the Cdc25 family of phosphatases [12-14]. In
X. laevis, Wee1 kinase is present in pre-MBT embryos, but
degraded after the MBT [15]. Prior to the MBT in X. laevis
embryos, Wee1 and Myt1 act in opposition to Cdc25C,
inhibiting Cdk1 [10,11].
At the MBT, the profile of kinases and phosphatases regu-
lating Cdk activity is modified. Both Cdc25C and Myt 1
persist at relatively constant levels. In contrast, Cdc25A
levels drop beginning at the MBT and maternally encoded
Wee1 disappears at gastrulation when it is replaced by the
more active zygotic kinase, Wee2 [16]. It is likely that this
change in the ratio of kinase to phosphatase activity oper-
ating on the Cdks is an integral component of cell cycle
remodeling that initiates at the MBT. In previous studies
that support this hypothesis, overexpression of Cdc25A
accelerated [12], whereas overexpression of Wee2 length-
ened cleavage cycles [16].
In addition to its role in promoting S phase, cyclin E/Cdk2
also serves a developmental function in early X. laevis
embryos. Oscillations in cyclin E/Cdk2 activity constitute
a maternal developmental timer that regulates the timing
of the events of the MBT [9]. One of these events is the
degradation of maternal cyclin E itself [9,17,18]. Inhibi-
tion of Cdk2 by the specific Cdk inhibitor, ∆34Xic1,
lengthens cleavage and delays the onset of the MBT and
the degradation of cyclin E [9]. Although cyclin E levels
are constant throughout pre-MBT development, cyclin E/
Cdk2 activity oscillates twice per cell cycle, independently
of protein synthesis and the nucleo-cytoplasmic ratio
[9,17,19]. However, other inhibitors of the MBT such as
α-amanitin (blocks zygotic transcription) and cyclohex-
imide (blocks protein synthesis) do not affect the timing
of cyclin E degradation [9,20], suggesting that the cyclin
E/Cdk2 timer regulates the MBT but not vice versa. Over-
expression of cyclin E in the early embryo disrupts nuclear
divisions and triggers apoptosis after the MBT [21]. These
effects are independent of Cdk activity, suggesting further
complexity of the role of cyclin E during early develop-
ment. A better understanding of how the cyclin E/Cdk2
developmental clock is regulated should give insight into
the mechanisms that drive cell cycle remodeling at the
MBT.
It has been proposed that oscillatory activity of cyclin E/
Cdk2 is governed by changes in phosphorylation state
[18]. However, the kinases and phosphatases that govern
cyclin E/Cdk2 activity in X. laevis embryos are unknown.
Overexpression of Chk1 in X. laevis embryos, which acti-
vates Wee1 and inhibits Cdc25A and Cdc25C, delays both
the MBT and cyclin E degradation [22], suggesting that the
cyclin E/Cdk2 timer is regulated by its phosphorylation
state. In mammalian cells, Wee1 inhibits cyclin E/Cdk2
[23-25], but it was previously unknown whether Wee1
regulated cyclin E/Cdk2 activity in X. laevis.
Wee1 is the opposing kinase of Cdc25, is degraded after
the MBT, and functions to inhibit both cyclin B/Cdk1 in
metazoans and cyclin E/Cdk2 in mammals. Therefore, we
disrupted the balance of Cdk phosphatase and kinase
activity by overexpressing Wee1 in X. laevis embryos to
more closely identify its role in cell cycle remodeling dur-
ing the early embryonic development of X. laevis. Our
results indicate that an imbalance of Cdk-inhibitory activ-
ity triggers apoptosis, most likely through the disruption
of the cyclin E/Cdk2 timer, since direct inhibition of cyc-
lin E/Cdk2 also induces apoptosis. These data suggest that
proper coordination of cell cycle remodeling events at the
MBT is required for embryonic survival. By comparing the
developmental effects of Cdk inhibitors that trigger apop-
tosis to those that inhibit apoptosis, we identified Cdc25A
as an important predictor of developmentally regulated
apoptosis in X. laevis embryos.
Results
Overexpression of Wee1 lengthens pre-MBT cell cycles
To determine the effect of disrupting the balance of Cdk
kinase and phosphatase activities in embryos prior to the
MBT, 2.5 ng mRNA encoding wild-type Wee1 or luciferase
(control) was microinjected into one-cell stage embryos.
Western analysis confirmed expression of exogenous
Wee1 throughout the developmental stages examined
(Figure 1A). Embryos expressing exogenous Wee1 exhib-
ited slower cleavage cycles. At 4.5 hours post-fertilization
(hrs pf), embryos expressing exogenous Wee1 were
delayed by approximately one cell cycle compared to con-
trols embryos injected with luciferase mRNA (Figure 1B)
(Stage 6 = 32 blastomeres compared to Stage 7 = 64 blas-
tomeres) [26]. Otherwise, these embryos developed with
normal morphology through the MBT.
To determine whether the cell cycle lengthening induced
by exogenous Wee1 coincided with the phosphorylation
of Cdks, embryos expressing Wee1 or luciferase were
assayed by Western analysis using a phosphoCdk primary
antibody (Figure 1C). In untreated embryos, low-levelBMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Overexpression of Wee1 lengthens pre-MBT cell cycles Figure 1
Overexpression of Wee1 lengthens pre-MBT cell cycles. One-cell stage embryos were microinjected with 2.5 ng 
mRNA encoding Wee1 or luciferase (control). (A) Embryos were collected at indicated times post-fertilization (hr pf) and ana-
lyzed for Wee1 protein by Western analysis. (B) Xenopus embryos injected with 2.5 ng Wee1 or luciferase mRNA were pho-
tographed at 4.5 hr pf, when embryos expressing exogenous Wee1 were delayed approximately one cell cycle compared to 
luciferase controls. (C) Overexpression of Wee1 results in premature tyrosine phosphorylation of Cdks. Embryo lysates were 
subjected to Western analysis using a phosphoCdk antibody (Cell Signaling Technology). Both phosphorylated p34Cdk1 and 
p32Cdk2, are recognized by this antibody, which likely accounts for the bands of slower and faster mobility, respectively. Phos-
phorylation of Cdks was apparent as early as Stage 6 (3 hrs pf) in embryos injected with Wee1. (D) Embryos (n = 10) were col-
lected at the indicated stages, then DNA was isolated and resolved by agarose gel electrophoresis. Approximate timing of the 
MBT in luciferase expressing control embryos is indicated. E) Embryos were collected at Stage 9 (7 hrs pf), fixed, sectioned, 
stained with DAPI to visualize nuclear morphology, and photographed. A representative field is shown. scale bar = 50 µmBMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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tyrosine phosphorylation of Cdks occurs prior to the MBT
then increases at the MBT concurrent with cell cycle
lengthening [12,19,27]. Similarly, control embryos
expressing luciferase demonstrated low levels of Cdk
phosphorylation until the MBT. In contrast, Cdks were
phosphorylated on tyrosine 15 as early as 3 hrs pf in
embryos expressing exogenous Wee1, suggesting the cell
cycle delay resulted from the inhibition of Cdks.
Mitotic cleavage cycles and nuclear cycles of DNA replica-
tion can be uncoupled in early X. laevis embryos [1].
Therefore, we wanted to determine whether exogenous
Wee1 also affected DNA replication in early embryos.
Total DNA was isolated from embryos expressing Wee1 or
luciferase, resolved by gel electrophoresis and stained
with ethidium bromide. Embryos expressing exogenous
Wee1 contained less DNA throughout early development,
compared to luciferase controls (Figure 1D). However, the
DNA content increased through the early development of
embryos overexpresssing Wee1 indicative of continuing
DNA replication. The rate of increase in DNA content was
consistent with the lengthened cleavage cycles, suggesting
that nuclear and cytoplasmic cycles were coordinated. To
examine nuclear morphology, embryos were collected at
several stages, sectioned and stained with DAPI. Repre-
sentative fields from embryos collected at Stage 9 are
shown in Figure 1E. Embryos overexpressing Wee1 con-
tained interphase and mitotic nuclei with normal mor-
phology. There was no loss of nuclei as seen in embryos
overexpressing cyclin E [21], although there were fewer
and larger cells in these embryos, consistent with the
delayed cell cycles. These results indicate that the overex-
pression of Wee1 delays both nuclear and cleavage cycles,
but these cycles appear to remain coupled.
Overexpression of Wee1 triggers apoptosis after the MBT
In previous studies, we showed that X. laevis embryos
expressing exogenous checkpoint kinases, Chk1 or Chk2,
exhibited a similar cell cycle delay and premature Cdk
phosphorylation [28,29]. Furthermore, embryos express-
ing exogenous Chk2 developed normally through neuru-
lation and beyond, and exogenous Chk2 protects
embryos form apoptosis induced by ionizing radiation
[29].
Embryos overexpressing Wee1 developed normally
through the MBT until early gastrulation (~Stage 10.5).
However, during gastrulation, these embryos began to
appear abnormal, exhibiting a loss of cellular attachment
and overall organization (Figure 2A). The gross morphol-
ogy of embryos expressing exogenous Wee1 appeared
consistent with that of embryos that had undergone apop-
tosis in response to ionizing radiation [2,3], unreplicated
DNA, or expression of dominant-negative Chk1/Chk2
[4,29].
To determine whether the kinase activity of Wee1 was
required for its disruption of development, embryos were
microinjected with wild-type (WT) or kinase-dead (KD)
Wee1 mRNA (plasmids provided by Paul Mueller, Univer-
sity of Texas, San Antonio) [16]. The embryos expressing
KD Wee1 developed normally through gastrulation (Fig-
ure 2B), indicating that kinase activity is required for the
effects of exogenous Wee1.
To determine whether overexpression of Wee1 induced
apoptosis, embryos were assayed for caspase activity in
embryo lysates by the cleavage of exogenous human PARP
protein [4]. Embryos expressing exogenous Wee1 were
positive for caspase activity at gastrulation (Stage 11; ~12
hrs pf) indicated by the presence of a cleaved PARP frag-
ment (Figure 2C). These results were surprising since
exogenous Chk1 and Chk2, lengthen cleavage cycles and
promote phosphorylation to the same extent as Wee1, yet
exogenous Chk1 and Chk2 kinases inhibit rather than
promote apoptosis [4,29]. Like the effects on gross mor-
phology, the activation of caspases was dependent on
Wee1 kinase activity as caspase activity was not detected in
embryos expressing KD Wee (Figure 2D).
In X. laevis cell-free egg extracts, Wee1 accelerates apopto-
sis through interaction with an SH2 domain in the Crk-
adaptor protein. Furthermore, Wee1 can restore apoptosis
in extracts depleted of SH2 domain interactors [30]. To
determine whether Wee1 associates with Crk in develop-
ing X. laevis embryos undergoing apoptosis, Wee1 was
immunoprecipated from embryo extacts and the immu-
noprecipitates were immunoblotted for Crk. Constant
levels of Crk were detected even in lysates overexpessing
Wee1 (data not shown). This data indicate an association
between Crk and Wee1 in vivo, and that all available Crk
may be complexed with endogenous Wee1.
Overexpression of Wee1 promotes the persistence of 
Cdc25A, cyclin E and Cdk2 activity
In Xenopus embryos, the MBT delineates a point when a
host of cell cycle remodeling events occur. Among these
remodeling events are the degradation of maternal
Cdc25A [12] and cyclin E [19,31]. In previous studies, we
showed that overexpression of Chk1/Chk2 causes prema-
ture degradation of Cdc25A and delayed degradation of
cyclin E [22,29]. Furthermore, the transient activation of
Chk1 at the MBT is required for the degradation of
Cdc25A [32]. Since overexpression of Chk1, Chk2, and
Wee1 all lengthen the cell cycle and trigger premature
phosphorylation of Cdks, we wanted to investigate the
effect of exogneous Wee1 on the timing of Cdc25A and
cyclin E degradation, two hallmarks of the MBT.
Messenger RNA encoding wild-type Wee1 or luciferase
(control) was microinjected into one-cell stage embryos,BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Overexpression of Wee1 in early Xenopus embryos triggers apoptosis after the MBT Figure 2
Overexpression of Wee1 in early Xenopus embryos triggers apoptosis after the MBT. One-cell stage Xenopus 
embryos were microinjected with 2.5 ng wild-type (WT) Wee1, kinase-dead (KD) Wee1, or luciferase (control) mRNA. (A-B) 
Embryos expressing Wee1, KDWee1, and luciferase developed normally until the early gastrula stage, when embryos express-
ing exogenous WT Wee1 exhibited abnormal morphology consistent with apoptosis. Embryos shown were photographed at 
gastrulation (Stage 11). (C-D) Embryo extracts were collected at Stage 11 and incubated with recombinant human PARP, a 
substrate for caspase 3 [4]. The presence of a cleaved PARP fragment indicates caspase activity, a marker of apoptosis.BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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then embryos were collected at the indicated times and
subjected to Western analysis of Cdc25A and cyclin E.
Unlike Chk1/Chk2, overexpression of Wee1 resulted in
delayed rather than accelerated degradation of Cdc25A
(Figure 3A).
Additionally, overexpression of Wee1 delayed the degra-
dation of cyclin E until mid-gastrulation (Figure 3B), sim-
ilar to overexpression of Chk1 [22] and the expression of
exogenous ∆34-Xic1 [9]. Both Chk1 and ∆34-Xic1 inhibit
cyclin E/Cdk2 in embryos and are the only reagents
known to delay the timing of cyclin E degradation in X.
laevis embryos. This evidence and the prediction of our
mathematical model suggest that timing of cyclin E degra-
dation is determined by cyclin E/Cdk2 activity itself [18].
Therefore, we hypothesized that Wee1 may also inhibit
cyclin E/Cdk2 in X. laevis embryos.
Inhibition of Cdk1 by Wee1 has been well characterized
in X. laevis and other systems [10,33-35]. In human HeLa
cells, Wee1 also phosphorylates Cdk2, inhibiting entry
into S-phase [23-25]. In order to determine whether Wee1
inhibits Cdk2 in early X. laevis embryos, cyclin E was
immunoprecipitated from embryos overexpressing Wee1,
and Western analysis was performed on the immunopre-
cipitates to detect inhibitory tyrosine phosphorylation on
Cdk2. Embryos overexpressing Wee1 expressed higher
levels of phosphorylated Cdk2 (PCdk) indicating inhibi-
tion of Cdk2 by Wee1 (Figure 3C). These results suggest
that the delays in degradation of cyclin E and Cdc25A by
the overexpression of Wee1 could be due to the inhibition
of Cdk2. The inhibition of cyclin E/Cdk2 is also consistent
with the reduced DNA content in embryos expressing
Wee1, since cyclin E/Cdk2 promotes the initiation of
DNA replication during S phase [36,37].
To more directly measure Cdk activity, cyclin E immuno-
precipitates were tested for kinase activity against histone
H1. Immunoprecipatates were incubated with histone H1
and γ-32P ATP, reactions were resolved by polyacrylamide
gel electrophoresis, H1 bands were excised, and counted
by scintillation counting (Figure 3D). Despite the
increased tyrosine phosphorylation of Cdk2 in embryos
overexpressing Wee1, Cdk2 kinase activity was not
repressed. In fact, Cdk2 activity persisted in these embryos
after it had decreased after the MBT in control embryos.
The persistence of Cdk2 is consistent with the delay in cyc-
lin E degradation (Figure 3B). However, it was surprising
that Cdk2 activity was not reduced since we had observed
tyrosine phosphorylation of Cdk2 (Figure 3C) and this
phosphorylation event is known to inhibit Cdk2 activity
[28,36]. One explanation may be that exogenous Wee1
only phosphorylates a fraction of Wee1. Whether this frac-
tion represents a specific pool that is inhibited or repre-
sents a steady state of total Cdk2 is not known.
Inhibition of Cdk2 Triggers Apoptosis
Overexpression of Wee1 in Xenopus embryos resulted in a
post-MBT apoptotic death. Since the overexpression of
Wee1 not only alters cell cycle remodeling events (Figure
3) and the concentration of DNA at the MBT (6 hr pf; Fig-
ure 1D), but also phosphorylates Cdk2 (Figure 3), we
wanted to determine whether inhibition of Cdk2 contrib-
uted to the induction of apoptosis. In order to inhibit
Cdk2 directly, one-cell stage embryos were injected with
∆34-Xic1 protein or p27Xic1CK- protein as a control. The
∆34-Xic1 protein is a truncated form of the full length-
Xic1 that specifically inhibits the activity of cyclin E/Cdk2
in X. laevis [38]. In X. leavis embryos, the expression of
∆34-Xic1 delays the degradation of cyclin E, thereby dis-
rupting the cyclin E/Cdk2 timer [9]. The p27Xic1CK- con-
struct contains four point mutations in the Cdk2 binding
site that inhibit p27Xic1/Cdk2 interaction, thus serving as
a negative control.
Embryos expressing ∆34-Xic1 were delayed slightly (~1
cell cycle at the MBT) compared to p27Xic1CK- controls
(Figure 4A) but developed otherwise normally through
the MBT. However, prior to gastrulation, embryos express-
ing ∆34-Xic1 died by apoptosis, indicated by gross mor-
phology (Figure 4A) and activation of caspases (Figure
4B). In contrast, embryos injected with p27Xic1CK- pro-
tein persisted through gastrulation and neurulated (Figure
4A). These data indicate that specific inhibition of Cdk2
results in apoptosis in Xenopus embryos.
Discussion
In this study, we demonstrate that altering the balance of
Cdk tyrosine kinase and phosphatase activity in early X.
laevis embryos leads to apoptosis after the MBT. We initi-
ated these experiments because our previous studies sug-
gested Chk1/Chk2 kinases function as inhibitors of
apoptosis in early X. laevis embryos [4,29]. Expression of
catalytically inactive, dominant-negative Chk1 or Chk2 in
pre-MBT embryos induces apoptosis during early gastrula-
tion [4,29]. Furthermore, wild-type Chk2 rescues embryos
from radiation-induced apoptosis [29]. Because exoge-
nous Chk2 lengthens cleavage cycles in a dose-dependent
manner, one possible explanation for the protection from
apoptosis was that longer cell cycles allowed time for
repair of DNA damage. If this were the case, then Wee1,
which also lengthens cleavage cycles due to tyrosine phos-
phorylation of Cdks, should also protect embryos from
DNA damage-induced apoptosis.
However, the studies reported here yielded unexpected
results and valuable information regarding the role and
regulation of Cdk phosphorylation states in the early
embryo. Wee1 mRNA lengthened cell cycles modestly,
and until the MBT (Figure 1A), embryos overexpressing
Wee1 were indistinguishable from those expressing lowBMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Overexpression of Wee1 delays the MBT and alters Cdk2 Figure 3
Overexpression of Wee1 delays the MBT and alters Cdk2. Embryos were injected at the one-cell stage with 2.5 ng of 
Wee1 or luciferase (control) mRNA. (A, B) Embryos were collected at the indicated stages and lysates were subjected to 
Western analysis using (A) Cdc25A and (B) cyclin E antibodies. Approximate timing of the MBT in luciferase expressing control 
embryos is indicated. (C) Embryos were collected at 4 hrs pf and lysates were immunoprecipitated with cyclin E serum. Immu-
noprecipitates were subjected to Western analysis using a primary phosphoCdk antibody (Cell Signaling Technology). (D) Cyc-
lin E immunoprecipitates were collected at the times indicated and assayed for Cdk2 activity by phosphoryation of histone H1. 
The amount of γ-32P ATP incorporated in histone H1 is expressed as radioactive counts per minute (CPM).BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Inhibition of Cdk2 triggers apoptosis Figure 4
Inhibition of Cdk2 triggers apoptosis. One-cell stage embryos were injected with 5 ng of ∆34-Xic1 or p27Xic1CK- (con-
trol) protein. (A) Embryos expressing ∆34-Xic1 were delayed approximately one cell cycle at Stage 8 (5 hr pf) compared to 
p27Xic1CK- controls. At Stage 11 (12 hr pf), embryos expressing ∆34-Xic1 exhibited abnormal morphology consistent with 
apoptosis compared to p27Xic1CK- controls, which gastrulated. p27Xic1CK- controls continued to develop through gastrula-
tion and formed a neural groove, evident at Stage 13 (16 hr pf). (B) Extracts of Stage 11 embryos were incubated with recom-
binant PARP, a substrate for caspase 3 [4]. The presence of a cleaved PARP fragment indicates caspase activity. Replicate 
samples are shown.BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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levels of exogenous Chk2 [29]. Both groups of embryos
were delayed approximately one cell cycle when sibling
controls reached the MBT. Furthermore, the extent of tyro-
sine phosphorylation was similar in embryos expressing
exogenous Chk2 or Wee1. Despite these similarities,
embryos injected with Wee1 mRNA died by apoptosis in
the absence of any further perturbation.
Previous studies have implicated Wee1 as an inhibitor of
Cdk2 activity in mammalian cells [23-25], but Wee1 had
only been reported as a Cdk1 kinase in X. laevis embryos.
In this study, we demonstrated that Wee1 delayed the deg-
radation of cyclin E and phosphorylation of Cdk2, which
functions as a developmental timer until the MBT. How-
ever, the catalytic activity of the total pool of cyclin E/
Cdk2 was not reduced and persisted in embryos overex-
pressing Wee1, consistent with the cell cycle delay and
delayed degradation of cyclin E. Therefore, like Chk1/
Chk2, Wee1 causes tyrosine phosphoryation of Cdk1 and
Cdk2 in X. laevis embryos. Nonetheless, despite similar
effects on the cell cycle machinery, they have opposite
effects regarding apoptosis in the embryo.
Because we discovered Wee1 to alter Cdk2 phosphoryla-
tion as well as trigger apoptosis, we tested whether apop-
tosis could be induced by a more specific Cdk2 inhibitor.
A variant of Xic1 lacking the first 34 amino acids (∆34-
Xic1) is a specific stoichiometric inhibitor of cyclin E/
Cdk2 [38] and delays both the degradaton of cyclin E and
the onset of the MBT in X. laevis embryos [9]. In our stud-
ies, one hundred percent of embryos injected with exoge-
nous ∆34-Xic1 underwent apoptosis after the MBT (Figure
4). Similarly, in breast cancer cells, transduction of a non-
degradable form of the human homolog of Xic1, Kip1,
induced cell cycle arrest, thereby inhibiting cellular prolif-
eration. Furthermore, exogenous Kip1 caused an increase
in the number of apoptotic cells [39].
Conclusion
Table 1 and Figure 5 summarize the effects of three differ-
ent types of Cdk inhibitors on early development in X. lae-
vis  [4,29]. Exogenous Chk1/2, Wee1, and ∆34-Xic1 all
modestly lengthen cleavage cycles, and delay the degrada-
tion of cyclin E, thus delaying the timing of the MBT.
Whereas Chk1/2 and Wee1 inhibit Cdk1 and cause phos-
phorylation of Cdk2, ∆34-Xic1 is a specific inhibitor of
Cdk2. These data stress the importance of cyclin E/Cdk2
in the timing of early developmental events.
Despite similar effects on development prior to the MBT,
only Wee1 and ∆34-Xic1 induce apoptosis, whereas
Chk1/Chk2 function as inhibitors of apoptosis. One pos-
sible explanation for this difference apparent in Table 1 is
the effect of these reagents on Cdc25A levels at the MBT
and consequently on the ratio of Cdk kinases:phos-
phatases at the MBT. Chk1/Chk2 trigger the premature
degradation of Cdc25A before the MBT whereas Wee1 and
∆34-Xic1 delay the degradation of Cdc25A. These data
suggest that Cdc25A may promote apoptosis and/or that
a high Cdk kinase:phosphatase ratio inhibits apoptosis. In
support of the former, exogenous non-degradable
Cdc25A triggers cell death in the embryo during early gas-
trulation [32]. In support of the latter Chk1/Chk2 may
activate Wee1 in X. laevis, leading to an even higher Cdk
kinase:phosphatase level than would be achieved by the
degradation of Cdc25A alone [40]. Alternatively, Chk1/
Chk2 may block apoptosis by another pathway alto-
gether, distinct from their effect on the cell cycle machin-
ery. These studies illustrate that cell cycle remodeling
events must be appropriately coordinated for the embryo
to develop beyond the MBT. These studies also illustrate
that cell cycle regulators that have been well characterized
biochemically in vitro or in cell culture systems may have
additional functions that can be uncovered in the rich
context of the developing embryo.
Methods
Manipulation and maintenance of embryos
Eggs from wild-type Xenopus laevis (Xenopus Express) were
fertilized in vitro, dejellied in 2% cysteine in 0.1× MMR
(0.5 mM HEPES, pH 7.8, 10 mM NaCl, 0.2 mM KCl, 0.1
mM MgSO4, 0.2 mM CaCl2, 0.01 mM EDTA), and main-
tained in 0.1× MMR. Embryos were staged [26] and sub-
jected to manipulation. Embryos were injected at the one-
cell stage with specific concentrations of Wee1 or luci-
ferase mRNA dissolved in 25–30 nL TE buffer (10 mM
Tris, pH 8.0, 1 mM EDTA). In other experiments, embryos
were injected with ∆34-Xic1 [38] and p27Xic1CK- protein
diluted in buffer (20 mM Hepes, pH 7.5, 88 mM NaCl, 7.5
mM MgCl2, 10 mM β-mercaptoethanol). ∆34-Xic1 lacks
the first 34 amino acids of the p27Xic1 protein.
p27Xic1CK- has the conserved residue in the kinase
domain mutated (R33A, L35A, F65A, F67A). Embryos
were observed with an Olympus SZX12 stereomicroscope
and photographed with an Olympus DP10 digital camera.
In Vitro Transcription of Wee1 mRNA
Wee1 cDNA in pBluescript was kindly provided by Dr.
Monica Murakami (National Cancer Institutes. Plasmids
encoding Wee1 were linearized and used as templates to
produce polyadenylated mRNA using the Ambion T3
mMessage mMachine in vitro transcription kit (Ambion).
The control mRNA encoding exogenous luciferase protein
was prepared as described previously [28]. Experiments
with kinase-dead and wild-type Wee1 mRNA were per-
formed with constructs provided by Dr. Paul Mueller
(University of Texas at San Antonio). In the kinase-dead
mutant, the codon for lysine 239 was converted to the
codon for arginine.BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Effects of inhibitors of Cdk activity on early development of X. laevis Figure 5
Effects of inhibitors of Cdk activity on early development of X. laevis. (A) Exogenous Chk1/2 indirectly inhibits Cdk1 
and Cdk2 by targeting Cdc25A for degradation. Onset of the MBT is delayed, but development proceeds without apoptosis. 
(B) Exogenous Wee1 phosphorylates Cdk1 and Cdk2. The total pool of Cdk1 activity is inhibited. Onset of the MBT including 
degradation of Cdc25A is delayed. Embryos die by apoptosis during early gastrulation. (C) Exogenous ∆34-Xic1 inhibits Cdk2 
but not Cdk1. Like Wee1, ∆34-Xic1 delays the MBT including degradation of Cdc25A, and induces apoptosis.BMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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Western Analysis
Embryos were lysed in EB buffer (20 mM HEPES, pH 7.5,
80 mM β-glycerophosphate, 15 mM MgCl2, 20 mM EGTA,
50 mM NaF, 1 mM sodium orthovanadate, 1 mM dithio-
threitol, 1 mM phenylmethylsulfonyl fluoride, 20 mg/mL
leupeptin, 1 mM microcystin). Samples were then
resolved on SDS polyacrylamide gels), transferred to a
nitrocellulose membrane and blocked in 3% nonfat dry
milk in TBS- 0.1%Tween (tris-buffered saline- 20 mM
Tris-Base, 0.14 M NaCl, pH-7.6) or 5% BSA in TBS – 0.1%
Tween. Membranes were incubated in primary antibody
against Cdc25A and cyclin E (gifts from Dr. James Maller),
and Wee1 (1:1000) (Zymed), diluted in 5% BSA-TBS-
0.1% Tween overnight at 4°C. Membranes were washed
then incubated in secondary antibody (Peroxidase-conju-
gated AffiniPure Donkey Anti-Rabbit IgG (Jackson
Immuno Research Laboratories Inc.) 1:10,000 in TBS-
0.1% Tween. Immunoreactive proteins were detected by
chemilluminescence using an ECL Plus kit (Amersham).
Isolation and visualization of genomic DNA
Embryos were injected with Wee1 or luciferase mRNA,
collected at indicated times, and lysed in DNA digestion
buffer (10 mM Tris, 100 mM EDTA, 50 µg/mL RNase,
0.5% SDS). Lysates were incubated at 37°C for 2 hrs. Pro-
teinase K was then added to a final concentration of 100
µg/mL with continued incubation at 50°C for 4 hrs with
slight intermittent manual agitation. Genomic DNA was
phenol/chloroform extracted, and precipitated overnight
at -20°C in 100% ethanol. Samples were resuspended in
TE, and resolved on a 0.7% agarose gel, and ethidium bro-
mide-stained DNA was visualized and photographed
under UV illumination.
Assessment of nuclear morphology
Embryos were collected at the times indicated, fixed in 4%
paraformaldehyde, dehydrated through an ethanol series,
cleared in CitriSolv (Fisher), embedded in paraffin, sec-
tioned 7 µm thick, deparaffinized, rehydrated, and
stained with 1 µg/ml DAPI. Serial sections were viewed
and photographed on an Olympus AX70 fluorescence
microscope equipped with a Color View 12 digital cam-
era.
Assay for cleavage of PARP
Embryos previously injected with Wee1 and luciferase
mRNA or ∆34-Xic1 and p27Xic1CK- proteins were col-
lected at desired stages (post-gastrulation), snap frozen on
dry ice, and assayed for the cleavage of exogenous PARP
[4]. Specifically, embryos were homogenized in caspase
extraction buffer (10 µl/embryo) (CEB: 80 mM β-glycero-
phosphate, 15 mM MgCl2, 20 mM EGTA, 10 mM DTT).
Lysates were incubated with 2 ng/mL recombinant
human PARP (Alexis Biochemicals) at 27°C for 15 min,
resolved on an SDS-polyacrylamide gel, and transferred to
a nitrocellulose membrane. Anti-PARP (1:5000) and
HRP-conjugated anti-rabbit (Cell Signaling Technology)
(1:2000) diluted in 10% nonfat dry milk in PBS were used
as primary and secondary antibodies, respectively. Both
full-length and cleaved PARP proteins were detected by
chemiluminescence using an ECL Plus kit (Amersham).
Immunoprecipitation-Western analysis and kinase assays
Embryos were injected with Wee1 or luciferase mRNA,
collected at indicated times, and lysed in EB. Antiserum
against cyclin E (gift from Dr. James Maller) was used to
immunoprecipitate cyclin E/Cdk2 or antibodies against
Wee1 (Zymed) were used to precipitate Wee1 and associ-
ated proteins. Embryos lysates were precleared with pro-
tein G Sepharose beads (Sigma, St. Louis, MO) for 30 min,
then mixed with antibodies, and incubated overnight on
ice. Protein G Sepharose beads were added the next day
and incubated with the immunoprecipitates for 1 h with
rotation. Beads were then washed twice in low-salt buffer
(20 mM Tris, pH 7.4, 5 mM EDTA, 0.1% Triton ×-100,
100 mM NaCl) and twice in high-salt buffer (20 mM Tris,
pH 7.4, 5 mM EDTA, 0.1% Triton ×-100, 1 M NaCl).
Immunoprecipitates were then mixed with 2× gel loading
buffer (1× = 0.6 mM Tris base, 2% glycerol, 3% SDS,
0.002% bromphenol blue) containing 10 mM n-ethyl-
maleimide, and resolved on an SDS-polyacrylamide gel.
Western analysis of cyclin E precipitates was performed as
described using a primary phospho-Cdk antibody (Cell
Signaling Technology) diluted 1:1000 or a monoclonal
Crk antibody (BD Biosciences) diluted 1: 5000 in 5%
BSA-TBS-Tween and a secondary HRP anti-rabbit or anti-
mouse antibody (Cell Signaling Technology) diluted
1:2000 in 5% BSA-TBS- 0.1% Tween.
Table 1: Effects of three Cdk inhibitors on early development of the X. laevis embryo
effect on: Chk1/2 Wee1 ∆34Xic1
cleavage cycles dose-dependent lengthening [28, 29] modest lengthening modest lengthening [9]
Cdk1 activity inhibits via Tyr phosphorylation [28] inhibits via Tyr phosphorylation [10] no effect [38]
Cdk2 activity inhibits via Tyr phosphorylation [29] persists with Tyr phosphorylation stoichiometric inhibitor [38]
degradation of cyclin E delayed [28] delayed delayed [9]
degradation of Cdc25A premature [22, 29, 32] delayed delayed
Cdk kinase:ppase activity at the MBT increased kinase: decreased ppase [32, 40] increased kinase: decreased ppase unknown kinase: decreased ppase
effect on apoptosis inhibits [4, 29] activates activatesBMC Developmental Biology 2007, 7:119 http://www.biomedcentral.com/1471-213X/7/119
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For kinase assays, immunoprecipitates were washed twice
in kinase buffer (20 mM HEPES, pH 7.5, 15 mM MgCl2,
5 mM EGTA, 1 mM dithiothreitol), and then incubated 20
min at 27°C with 25 µl of kinase buffer containing 0.2
mg/ml bovine serum albumin, 0.5 mg/ml histone H1,
200 µM [γ-32P]ATP [2 cpm/fmol]). Reactions were termi-
nated with 25 µl of 2× gel loading buffer containing 25%
β-mercaptoethanol, heated at 95°C for 2 min, and
resolved by PAGE. The gels were stained with Coomassie
Blue and dried. Incorporation of [γ-32P]ATP was deter-
mined by Cerenkov scintillation counting of the excised
histone H1 band.
Generation and purification of p27Xic1CK- protein
Rosetta cells (Novagen) were transformed with pGEX vec-
tor encoding the GST-p27Xic1CK- containing 4 mutations
in p27Xic1 (R33A, L35A, F65A, F67A). Bacterial pellets
were resuspended in buffer × (50 mM Tris pH 8, 250 mM
NaCl, 1 mM EDTA, 1 mM EGTA) containing 1 tablet of
Complete protease inhibitors (Roche) and 1 mM DTT.
Cell suspension was incubated at room temperature with
100 µg/mL lysozyme for 20 min with stirring then for an
additional five minutes with 1/20 volume 10% Triton ×-
100. Cell suspension was then sonicated 2 × 30 seconds
and centrifuged at 17,510 × g for 1 hr at 4°C. The super-
natant fraction was loaded onto a column of glutathione-
agarose beads (Sigma) previously equilibrated with 5 vol-
umes of extraction buffer (50 mM Tris pH 8, 250 mM
NaCl, 1 mM EDTA, 1 mM EGTA). Supernatant was passed
through the column twice. The column was then washed
with 10 volumes of buffer A (50 mM Tris pH 8.0, 0.5 M
NaCl, 1 mM EDTA, 1 mM EGTA, 5 mM DTT) and 10 vol-
umes of buffer B (20 mM Tris pH 8.0, 1 M NaCl, 1 mM
EDTA, 1 mM EGTA, 5 mM DTT). p27Xic1CK- protein was
eluted with 5 mL buffer × containing 100 mM glutathione
(GSH;Sigma), pH 8.0. Purified p27Xic1CK- was then con-
centrated by buffer exchange using Amicon Ultra Ultracel
low binding regenerated cellulose tubes (Millipore, Bed-
ford, MA), resuspended in buffer (20 mM Hepes pH 7.5,
88 mM NaCl, 7.5 mM MgCl2, 10 mM β-mercaptoethanol)
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